Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2016 6
2017 6
2019 3
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1.
D'Alterio C, Buoncervello M, Ieranò C, Napolitano M, Portella L, Rea G, Barbieri A, Luciano A, Scognamiglio G, Tatangelo F, Anniciello AM, Monaco M, Cavalcanti E, Maiolino P, Romagnoli G, Arra C, Botti G, Gabriele L, Scala S. D'Alterio C, et al. Among authors: buoncervello m. J Exp Clin Cancer Res. 2019 Oct 28;38(1):432. doi: 10.1186/s13046-019-1420-8. J Exp Clin Cancer Res. 2019. PMID: 31661001 Free PMC article.
α-Adrenoceptor stimulation attenuates melanoma growth in mice.
Maccari S, Buoncervello M, Ascione B, Stati T, Macchia D, Fidanza S, Catalano L, Matarrese P, Gabriele L, Marano G. Maccari S, et al. Among authors: buoncervello m. Br J Pharmacol. 2022 Apr;179(7):1371-1383. doi: 10.1111/bph.15731. Epub 2022 Jan 26. Br J Pharmacol. 2022. PMID: 34766341
Preclinical models in the study of sex differences.
Buoncervello M, Marconi M, Carè A, Piscopo P, Malorni W, Matarrese P. Buoncervello M, et al. Clin Sci (Lond). 2017 Mar 1;131(6):449-469. doi: 10.1042/CS20160847. Clin Sci (Lond). 2017. PMID: 28265036 Review.
CXCR4-antagonist Peptide R-liposomes for combined therapy against lung metastasis.
Ieranò C, Portella L, Lusa S, Salzano G, D'Alterio C, Napolitano M, Buoncervello M, Macchia D, Spada M, Barbieri A, Luciano A, Barone MV, Gabriele L, Caraglia M, Arra C, De Rosa G, Scala S. Ieranò C, et al. Among authors: buoncervello m. Nanoscale. 2016 Apr 14;8(14):7562-71. doi: 10.1039/c5nr06335c. Nanoscale. 2016. PMID: 26983756
Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice.
Maccari S, Buoncervello M, Rampin A, Spada M, Macchia D, Giordani L, Stati T, Bearzi C, Catalano L, Rizzi R, Gabriele L, Marano G. Maccari S, et al. Among authors: buoncervello m. Br J Pharmacol. 2017 Jan;174(2):139-149. doi: 10.1111/bph.13662. Epub 2016 Nov 30. Br J Pharmacol. 2017. PMID: 27792834 Free PMC article.
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.
Santagata S, Napolitano M, D'Alterio C, Desicato S, Maro SD, Marinelli L, Fragale A, Buoncervello M, Persico F, Gabriele L, Novellino E, Longo N, Pignata S, Perdonà S, Scala S. Santagata S, et al. Among authors: buoncervello m. Oncotarget. 2017 Aug 19;8(44):77110-77120. doi: 10.18632/oncotarget.20363. eCollection 2017 Sep 29. Oncotarget. 2017. PMID: 29100374 Free PMC article.
18 results